We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.
In 2024, about 20% of roughly 18,000 users signed up for a Super Cruise subscription after the complimentary subscription ended, Barra said. Another 33,000 vehicles will end a three-year trial period ...